Ligand id: 9107

Name: cabiralizumab

Compound class Antibody
International Nonproprietary Names
INN number INN
10121 cabiralizumab
BMS-986227 | FPA-008 | FPA008
Cabiralizumab is an investigational humanized monoclonal antibody targeting the receptor tyrosine kinase, CSF1R (Fms). It is being investigated for its potential anti-cancer activity.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent US20110274683 [1]
Database Links
Specialist databases
IMGT/mAb-DB 587
Other databases
GtoPdb PubChem SID 315661192
Search PubMed clinical trials cabiralizumab
Search PubMed titles cabiralizumab
Search PubMed titles/abstracts cabiralizumab